final bnpcw hypertension

28
 Antihyperten Antihyperten sive sive drugs drugs

Upload: pradeep-kumar

Post on 30-May-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 1/28

 

AntihypertenAntihyperten

sivesive drugsdrugs

Page 2: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 2/28

 

Blood PressureBlood Pressure

Page 3: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 3/28

 

Normal Regulation Of BloodNormal Regulation Of Blood

PressurePressure

Page 4: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 4/28

 

Contd.,Contd.,

Page 5: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 5/28

 

Contd.,Contd.,

Any condition that affectsAny condition that affects heart rateheart rate,, stroke volumestroke volume or or 

 peripheral vascular resistance peripheral vascular resistance affectsaffects arterial blood pressurearterial blood pressure

Compensatory mechanisms to maintain balance betweenCompensatory mechanisms to maintain balance betweenhypotension and hypertensionhypotension and hypertension

 Vascular endothelium produces vasodilating substances

(nitric oxide, prostacyclin) which reduce blood pressure

Page 6: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 6/28

 

Contd.,Contd.,

BP regulation operates in aBP regulation operates in a negative feedback systemnegative feedback system

BaroreceptorsBaroreceptors andand chemoreceptorschemoreceptors in thein the carotid arteriescarotid arteries andand aorticaorticarcharch detect changes in arterial blood pressure and indetect changes in arterial blood pressure and in pO2, pCO2 pO2, pCO2 andand H+H+..

Increased BP results inIncreased BP results in increased stretchincreased stretch of vessels; activation of of vessels; activation of vagus and stimulation of medulla via sympathetic or vagus and stimulation of medulla via sympathetic or  parasympathetic pathways. parasympathetic pathways.

Page 7: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 7/28

 

Contd.,Contd.,

 Normally, when the arterial blood pressure is elevated Normally, when the arterial blood pressure is elevatedKidneysKidneys will excrete more fluidwill excrete more fluid

Fluid lossFluid loss will result inwill result in decreased ECF volumedecreased ECF volume andand blood blood

volumevolume

Decreased blood flowDecreased blood flow to the heart willto the heart will reduce cardiac outputreduce cardiac output

Decreased CODecreased CO reduces arterial blood pressurereduces arterial blood pressure

Page 8: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 8/28

 

Compensatory mechanismsCompensatory mechanisms

Baroreceptor reflexBaroreceptor reflex ↑BPBP → ↑baroreceptor stretchbaroreceptor stretch → ↑afferent nerve trafficafferent nerve traffic

activity inhibitsactivity inhibits vasomotor centrevasomotor centre

↓Sympathetic toneSympathetic tone 

↓HR,HR, ↓

LV contractility (LV contractility (↓

SV) andSV) and

arteriolar vasodilatationarteriolar vasodilatation →  ↓BPBP

Page 9: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 9/28

 

Baroreceptor reflexBaroreceptor reflex

Page 10: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 10/28

 

Page 11: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 11/28

 

Baroreceptor reflexBaroreceptor reflex

Page 12: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 12/28

 

Page 13: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 13/28

 

DefinitionDefinition

Elevation of Elevation of arterial blood pressure abovearterial blood pressure above140/90 mm Hg140/90 mm Hg. Can be caused by:. Can be caused by: an underlying disease processan underlying disease process

((secondary hypertensionsecondary hypertension))• Renal artery stenosisRenal artery stenosis

• HyperaldosteronismHyperaldosteronism

• pheochromocytomapheochromocytoma

• Cushing’syndromeCushing’syndrome idiopathic process (idiopathic process (primaryprimary or or essentialessential

hypertensionhypertension))

Page 14: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 14/28

 

Types of HypertensionTypes of Hypertension

Essential or primaryEssential or primary —etiology ?. Contributors include: salt —etiology ?. Contributors include: salt

sensitivity, insulin resistance, genetics, sleep apnea, environmentalsensitivity, insulin resistance, genetics, sleep apnea, environmental

factors,othersfactors,others

SecondarySecondary —renal, adrenal, coarctation of aorta,steroids, pregnancy, —renal, adrenal, coarctation of aorta,steroids, pregnancy,

 pheochromocytoma, primary aldosteronism, cushing’s syndrome pheochromocytoma, primary aldosteronism, cushing’s syndrome

Page 15: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 15/28

 

JNC VII Causes of Secondary HypertensionJNC VII Causes of Secondary Hypertension

Medical Conditions

Chronic kidney disease

Primary hyperaldosteronism

Renovascular disease

Chronic steroid therapy

Cushing’s syndrome

Pheochromocytoma

Aortic coarctation

Thyroid or parathyroid disease

Sleep apnea

Drugs

NSAIDS

Oral contraceptives

Adrenal steroids

Sympathomimetics

Cyclosporine or tacrolimus

Erythropoietin

Ephedra, mu huang, bitter orange

Cocaine or amphetamines

Alcohol

Page 16: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 16/28

 

Essential HypertensionEssential Hypertension

Activation of Activation of sympathetic nervous systemsympathetic nervous system 

causing prolongedcausing prolonged vasoconstrictionvasoconstriction

Activation of Activation of RAASRAAS plays integral part as wellplays integral part as well

In combination, mechanisms cause prolongedIn combination, mechanisms cause prolongedincreased vascular resistance; this in turn resultsincreased vascular resistance; this in turn results

in a thickening of vessel walls,in a thickening of vessel walls, LessLess productionproduction

of of nitric oxide (vasodilator)nitric oxide (vasodilator) andand IncreasedIncreased

endothelin 1 (increased vascular tone)endothelin 1 (increased vascular tone)

Page 17: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 17/28

 

Essential HypertensionEssential Hypertension Contd..Contd..

Also felt thatAlso felt that hyperinsulinemiahyperinsulinemiaandand insulin resistanceinsulin resistance causecause

endothelial dysfunction byendothelial dysfunction by

enhanced oxygen free radicalenhanced oxygen free radical

mediated damage andmediated damage and

decreaseddecreased ↓↓nitric oxidenitric oxide

bioavailabilitybioavailability. Also is an. Also is an

increased sympatheticincreased sympatheticresponse ;results in increasedresponse ;results in increased

vascular tone andvascular tone and constrictionconstriction

Page 18: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 18/28

 

 Normal Normal

(SBP)(SBP) <120<120 / (DBP)/ (DBP) <80<80 mmHgmmHg

PrehypertensionPrehypertension

SBPSBP 120-139120-139 / DBP/ DBP 80-8980-89 mmHgmmHg

Stage 1 HypertensionStage 1 Hypertension

SBPSBP 140-159140-159 / DBP/ DBP 90-9990-99 mmHgmmHg

Stage 2 HypertensionStage 2 Hypertension

SBPSBP >> 160160 / DBP/ DBP >> 100100 mmHgmmHg

Blood Pressure ClassificationBlood Pressure Classification

according to the JNC 7according to the JNC 7

Page 19: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 19/28

Page 20: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 20/28

 

Major Risk Factors That IncreaseMajor Risk Factors That Increase

Mortality in HypertensionMortality in Hypertension

SmokingSmoking

DyslipidemiasDyslipidemias

Diabetes MellitusDiabetes Mellitus

Age >60Age >60

Gender: men, postmenopausal womenGender: men, postmenopausal women Family historyFamily history

Page 21: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 21/28

 

NonpharmacologicNonpharmacologic

Management of HypertensionManagement of Hypertension

Weight reductionWeight reduction

ExerciseExercise Salt restriction in dietSalt restriction in diet

Stress reductionStress reduction

DASH eating planDASH eating plan Moderation in alcohol intakeModeration in alcohol intake

Page 22: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 22/28

 

Antihypertensive DrugsAntihypertensive Drugs

Classes:Classes: Angiotensin converting enzyme inhibitors (ACEI)Angiotensin converting enzyme inhibitors (ACEI) Angiotensin II Receptor BlockersAngiotensin II Receptor Blockers AntiadrenergicsAntiadrenergics Calcium channel blockersCalcium channel blockers DiureticsDiuretics

Direct vasodilatorsDirect vasodilators Renin inhibitorsRenin inhibitors

Page 23: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 23/28

 

Page 24: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 24/28

 

Page 25: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 25/28

 

ACE Inhibitor: Mechanism of ActionACE Inhibitor: Mechanism of Action

Angiotensin II

Kininase II

Angiotensin I

Angiotensinogen

Inhibitor ACE

ReninBradykinin

Inactive Fragments

Sympathetic

Vasopressin

Aldosterone

Vasoconstriction

ACE=Angiotensin converting enzyme

Kininogen

Kallikrein

Vasodilation

Prostaglandins

tPA

Page 26: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 26/28

 

Page 27: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 27/28

 

Page 28: Final Bnpcw Hypertension

8/14/2019 Final Bnpcw Hypertension

http://slidepdf.com/reader/full/final-bnpcw-hypertension 28/28

ACE IACE I